Tulane taking part in diabetes prevention study

NEW ORLEANS (AP) — Tulane University School of Medicine says it is looking for volunteers to take part in a large-scale clinical trial to investigate if a vitamin D supplement helps prevent or delay Type 2 diabetes in some adults with higher-than-normal glucose levels.

Tulane’s Dr. Vivian Fonseca says the university is one of 20 sites across the country to take part in the National Institutes of Health-funded study. About 2,500 participants are being recruited.

The Vitamin D and Type 2 Diabetes study will investigate whether vitamin D3 will prevent or delay Type 2 diabetes in adults aged 30 or older who have “pre-diabetes.” Tulane says people with pre-diabetes have blood glucose levels that are higher than normal but not high enough to be called diabetes.

D2d is the first study to directly examine if a daily dose of 4,000 International Units of vitamin D helps prevent the onset of Type 2 Diabetes. Researchers speculate that vitamin D could reduce the diabetes risk by 25 percent. The study will also examine if gender, age or race affect the potential of vitamin D to reduce diabetes risk.

___

Online:

For more information: http://tulane.it/1azzIIK

Comments are closed.